GLP-1 Analogues Market Research 2025: Increasing Diabetes and Obesity Rates and a Strong R&D Pipeline Support Market Expansion – Forecast to 2030 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “GLP-1 Analogues Market” report has been added to ResearchAndMarkets.com’s offering. This report provides detailed information on glucagon-like peptide-1 (GLP-1) analogues. It analyzes market trends for GLP-1 analogues, with data from 2024, estimates from 2025, projections of compound annual growth rates (CAGRs) through 2030 (the forecast period 2025-2030) and regional markets for GLP-1 analogues. […]
OZEM Vs. THNR: Which Is The Better ETF In The GLP-1 And Weight Loss Space?
Post Content
STAT+: AstraZeneca looks to China for obesity drug candidates
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Oh, hi. Today, we discuss delays in the launch of TrumpRx. Also, Sanofi is deprioritizing its mRNA flu vaccine. The need-to-know this morning Regeneron Pharmaceuticals expects an FDA approval decision in the first half […]
Serena Williams flaunts dramatic weight loss in GLP-1 Super Bowl ad
Serena Williams flaunts dramatic weight loss in GLP-1 Super Bowl ad originally appeared on The Sporting News. Add The Sporting News as a Preferred Source by clicking here. Serena Williams took to social media to tease her buzz-worthy Super Bowl ad. In the clip, she flaunts her dramatic weight loss in an ab-baring top and […]
The rise of ‘agonorexia’: People are developing brand new eating disorders on GLP-1 agonist drugs
“No one says, ‘Here’s your GLP-1, by the way, you might get an eating disorder.’”
Should You Buy Eli Lilly Before Feb. 4?
Key Points Eli Lilly will need an outstanding performance, likely driven by tirzepatide, to see its shares jump after its quarterly update on Feb. 4. Even if that doesn’t happen, there are ample reasons to buy the stock. 10 stocks we like better than Eli Lilly › Eli Lilly (NYSE: LLY), the largest healthcare company […]
Biomedicines, Vol. 14, Pages 316: Mechanistic Links Between the Gut Microbiome and Longevity Therapeutics
Biomedicines, Vol. 14, Pages 316: Mechanistic Links Between the Gut Microbiome and Longevity Therapeutics Biomedicines doi: 10.3390/biomedicines14020316 Authors: Noelia Garzon-Escamilla Miriam Medina-Cardena Preeti Roy Jessica Trent Joud Jamous Yalini Somesan Sandy J. Denslow Aging is a multifactorial biological process marked by the progressive decline in cellular and physiological functions, increasing susceptibility to chronic diseases and […]
Cuomo vs. O’Reilly heated debate, GLP‑1 lawsuits, government shutdown looms | CUOMO Full Show 1/28
Chris Cuomo warns that Congress is again heading toward a potential government shutdown as tensions rise over ICE tactics following recent incidents in Minnesota. While Democrats are pushing for reforms, he explains that a shutdown would not halt ICE or Border Patrol operations, since these agencies are funded through separate long‑term appropriations. Pro Football Hall […]
Alert as health watchdog warns patients weight loss jabs can trigger life-threatening side effect: ‘It’s important to know the symptoms’
Health chiefs have warned that GLP-1 medication increases risk of developing severe inflammation of the pancreas – which can be fatal.
Först en pizza, sedan en GLP-1-hämmare
Vykortet | New York